Tenet Healthcare Corporation (THC)
NYSE: THC · Real-Time Price · USD
172.57
-5.93 (-3.32%)
At close: Jun 18, 2026, 4:00 PM EDT
172.57
0.00 (0.00%)
After-hours: Jun 18, 2026, 4:10 PM EDT

Tenet Healthcare Stock Forecast

Stock Price Forecast

According to 22 analysts polled by S&P Global, Tenet Healthcare stock has a consensus rating of "Strong Buy" and an average price target of $243.62. The average 1-year stock price forecast is 41.17% higher than the current stock price, while the lowest is $210 (+21.69%) and the highest is $288 (+66.89%).

Price Target: $243.62 (+41.17%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$210$243.62$245$288
Change+21.69%+41.17%+41.97%+66.89%

Analyst Ratings

The average analyst rating for Tenet Healthcare stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingDec '25Jan '26Feb '26Mar '26Apr '26May '26
Strong Buy141414141414
Buy555666
Hold233222
Sell100000
Strong Sell000000
Total222222222222

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
J.P. Morgan
J.P. Morgan
Buy
Maintains
$280$260
BuyMaintains$280$260+50.66%May 23, 2026
Bank of America Securities
Bank of America Securities
Buy
Maintains
$230
BuyMaintains$230+33.28%May 14, 2026
Robert W. Baird
Robert W. Baird
Hold
Maintains
$245$210
HoldMaintains$245$210+21.69%May 5, 2026
Barclays
Barclays
Buy
Maintains
$257$238
BuyMaintains$257$238+37.92%May 5, 2026
Scott Fidel
Goldman Sachs
Goldman Sachs
Buy
Maintains
$265$252
BuyMaintains$265$252+46.03%May 4, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
21.99B
from 21.31B
Increased by 3.20%
Revenue Next Year
22.35B
from 21.99B
Increased by 1.64%
EPS This Year
17.81
from 16.78
Increased by 6.12%
EPS Next Year
17.73
from 17.81
Decreased by -0.46%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
19.49B19.17B20.56B20.68B21.31B21.99B
Revenue Growth
10.46%-1.60%7.25%0.54%3.07%3.20%
Gross Profit
7.27B7.05B7.82B8.22B8.82B9.28B
Gross Margin
37.30%36.76%38.03%39.75%41.37%42.20%
Operating Income
2.56B2.49B2.81B3.22B3.77B3.78B
Net Income
914.00M411.00M611.00M3.20B1.41B2.18B
EPS
----16.7817.81
EPS Growth
----41.25%6.12%
Forward PE
13.959.5513.4011.7612.209.69
Free Cash Flow
1.56B103.88M903.00M2.33B1.68B2.64B
No. Analysts
-----19
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High22.2B
Avg22.0B
Low21.7B

Revenue Growth

Revenue Growth202620272028
High
4.0%
Avg
3.2%
Low
1.9%

EPS Forecast

EPS202620272028
High18.65
Avg17.81
Low16.83

EPS Growth

EPS Growth202620272028
High
11.1%
Avg
6.1%
Low
0.3%